Exosomes from different MSCs mediate PCD in myocardial cells after myocardial infarction

Exosomes from different MSCs mediate PCD in myocardial cells after myocardial infarction. MiR-144 and miR-486-5p in exosomes derived from bone marrow mesenchymal stem cells (BMMSC-Exos) and miR-21 in endometrial exosomes derived from mesenchymal stem cells (MSC-Exos) can inhibit apoptosis of hypoxic cardiomyocytes by targeting the PTEN/PI3K/AKT signaling pathway. MiR-21a-5p and miR-25-3p in BMMSC-Exos can reduce the apoptosis of hypoxic cardiomyocytes by downregulating the expression of proapoptotic genes such as FasL, PDPD4, Peli1, and PTEN. MiR-129-5p in BMMSC-Exos inhibits cardiomyocyte apoptosis by regulating the TRAF3/NF-κB signaling pathway. BMMSC-Exos induce autophagy in cardiomyocytes by activating the AMPK/mTOR and AKT/mTOR signaling pathways. Human BMMSC-Exos inhibit pyroptosis by inhibiting the expression of Caspase-1 and NLRP3. Moreover, miR-182-5p in BMMSC-Exos inhibit pyroptosis by inhibiting the expression of GSDMD. MiR-100-5p in exosomes derived from human umbilical cord mesenchymal stem cells (hUCMSC-Exos) inhibit pyroptosis by inhibiting the expression of FOXO3. HUCMSC-Exos reduce ischemic hypoxia-induced iron death in cardiomyocytes by targeting DMT1. LncRNA-UCA1 in human MSC-Exos and Lnc A2M-AS1 in human BMMSC-Exos inhibit myocardial cell apoptosis by adjusting the miR-873-5p/XIAP axis and miR-556-5p/XIAP axis, respectively
Exosomes from different MSCs mediate PCD in myocardial cells after myocardial infarction

Publication

Mechanisms and Optimization Strategies of Paracrine Exosomes from Mesenchymal Stem Cells in Ischemic Heart Disease (2023) Xiaorong Yin, et al. Stem Cells Int. 2023;2023(NA). Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID